Please assess the completion status of the following clinical trial:

Trial Title: Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18 years~* Suspicion of acute appendicitis and planned for diagnostic laparoscopy and eventual laparoscopic appendectomy~* Perforated appendicitis (diagnosed during surgery by the surgeon)~* Negative p-HCG (women)~* Written informed consent after written and verbal information (preoperatively for the intervention group and postoperatively for the control group)~Exclusion Criteria:~* Cannot understand, read or speak Danish~* Previous allergic reaction to fosfomycin, metronidazole, rhGM-CSF, or penicillins e.g. piperacillin or amoxicillin~* Diagnostic laparoscopy revealing normal appendix not requiring an appendectomy or appendicitis without perforation~* Other intra-abdominal pathology requiring surgical intervention at the same operation~* Known renal or hepatic disease or biochemical evidence at the time of admission~* Known hematologic disease in current medical treatment~* American Society of Anesthesiologists (ASA) physical status ≥4 (a patient with severe systemic disease that is a constant threat to life)~* Body weight \>110 kg~* Surgery converted to open appendectomy~* Anticipated compliance problems

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention group (Type: EXPERIMENTAL): None
- Control group (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).